Effect of nostril breathing patterns in the patients of Major Depressive Disorder.
Phase 1
Not yet recruiting
- Conditions
- Health Condition 1: F321- Major depressive disorder, singleepisode, moderate
- Registration Number
- CTRI/2023/12/060900
- Lead Sponsor
- Indian Council of Medical Research, New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Adults with clinically diagnosed major depressive disorder (MDD) as per DSM-V criteria
2.Either gender
3.Age between 18-45 years
4.Right-handed subjects
5.Subject should be able to give informed consent.
6.No prior exposure to yoga practices
Exclusion Criteria
H/O any psychiatric disorder other than depression
2. H/O substance abuse
3. Pregnancy
4. Chronic physical illnesses (excluded based on clinical history
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neurobiological mechanisms link alternate nostril breathing to serotonin modulation in F321 Major Depressive Disorder?
How does Phase I nostril breathing intervention compare to SSRIs in treating moderate single-episode depression?
Which biomarkers correlate with autonomic nervous system response to unilateral nasal breathing in MDD patients?
What adverse events are associated with prolonged unilateral nostril breathing in Phase I psychiatric trials?
Are there synergistic effects when combining nasal breathing patterns with ketamine-based depression therapies?